Affix Labs

Press release · 2026-04-21

Affix Labs raises €1 million for European expansion of Repeltec

Nijmegen, Netherlands, 21 April 2026. Affix Labs Netherlands B.V., a Dutch chemistry company, has closed a €1 million funding round led by VP Capital and Oost NL. The company's surface insect repellent replaces the neurotoxic active substances behind growing insect resistance with a water-based, controlled-release alternative. The new capital funds the European rollout.

Patented solubility and controlled release

The core innovation is a formulation method that dissolves oily, water-insoluble active substances into water-based systems. A controlled-release coating extends the working life of one application. The flagship product, Repeltec, contains no neurotoxic compounds.

“Affix Labs fits our investment thesis exactly: scientifically proven technology that replaces harmful chemistry with a durable, effective alternative. We're proud to back the team as they move into commercial scale-up.” Erica van Eeghen, Senior Manager Ventures, VP Capital.

A tightening European regulatory environment

EU rules on chemical pesticides are tightening. Germany's 2025 self-service ban pulled a broad category of neurotoxic insecticides from open retail shelves, and similar measures are being adopted in other member states.

“We invest where innovation creates measurable economic and environmental impact. Affix Labs has a market-ready solution for a global regulatory shift, and we're pleased to support the next phase of their growth.” Matthijs Berkelaar, Senior Investment Manager Tech, Oost NL.

Commercial expansion and B2B partnerships

With the new capital, Affix Labs is expanding distribution in Germany, France and Norway, with Austria and the United Kingdom to follow. Alongside its consumer range, the company is launching a white-label model under the name Powered by Affix Labs. FMCG companies, hospitality operators and pest control manufacturers can use it to bring the technology into their own product ranges.

About Affix Labs

Affix Labs is a Dutch chemistry company working to reduce dependence on neurotoxic pesticides. Its patented solubility technology and controlled-release systems turn oily active substances into water-based coatings that keep working on a surface long after a conventional spray would have evaporated.

About Oost NL

Oost NL, the East Netherlands Development Agency, strengthens the regional economy on behalf of the Ministry of Economic Affairs and Climate Policy and the provinces of Gelderland and Overijssel. It invests public funds in innovative companies that drive sustainability and economic resilience.

About VP Capital

VP Capital is a single family office based in Belgium and the Netherlands, with a 150-year operating history. The firm pursues an impact-first strategy across energy transition, agrifood, clean technology and the built environment. VP Capital is B Corp certified.

Media contact

Tom Sam, info@affixlabs.com, affixlabs.com